相似文献
1
2
Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin.
Pharmacotherapy. 2001 Dec;21(12):1468-72. doi: 10.1592/phco.21.20.1468.34482.
3
Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors.
Clin Infect Dis. 2002 Mar 15;34(6):861-3. doi: 10.1086/339075. Epub 2002 Feb 4.
4
Moxifloxacin-induced QT prolongation and torsades: an uncommon effect of a common drug.
Am J Med Sci. 2009 Aug;338(2):164-6. doi: 10.1097/MAJ.0b013e3181a3c2c9.
5
Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
Cardiol J. 2009;16(2):172-4.
6
QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications.
Cardiology. 2011;120(2):103-10. doi: 10.1159/000334441. Epub 2011 Dec 13.
7
Ciprofloxacin-induced torsade de pointes.
Int J Cardiol. 2006 Nov 10;113(2):239-41. doi: 10.1016/j.ijcard.2005.08.048. Epub 2005 Dec 28.
8
Moxifloxacin-induced torsades de pointes.
Cardiol J. 2008;15(1):71-3.
9
Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors.
Clin Pharmacol Ther. 2004 Mar;75(3):242-7. doi: 10.1016/j.clpt.2003.11.376.
10
Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.
Addiction. 2008 Dec;103(12):2062-4. doi: 10.1111/j.1360-0443.2008.02390.x.
引用本文的文献
1
Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms.
Nat Rev Cardiol. 2016 Jan;13(1):36-47. doi: 10.1038/nrcardio.2015.110. Epub 2015 Jul 21.
2
Efficacy and safety of levofloxacin in the context of other contemporary fluoroquinolones: a review.
Curr Ther Res Clin Exp. 2003 Nov;64(9):646-61. doi: 10.1016/j.curtheres.2003.11.003.
3
Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period.
Br J Clin Pharmacol. 2009 Jan;67(1):88-98. doi: 10.1111/j.1365-2125.2008.03319.x. Epub 2008 Nov 17.
4
Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin.
Br J Pharmacol. 2006 Apr;147(8):905-16. doi: 10.1038/sj.bjp.0706678.
5
Effects of three fluoroquinolones on QT analysis after standard treatment courses.
Ann Noninvasive Electrocardiol. 2006 Jan;11(1):52-6. doi: 10.1111/j.1542-474X.2006.00082.x.
6
QT prolongation with antimicrobial agents: understanding the significance.
Drugs. 2004;64(10):1091-124. doi: 10.2165/00003495-200464100-00005.
7
Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.
Drug Saf. 2003;26(2):109-20. doi: 10.2165/00002018-200326020-00004.
本文引用的文献
1
Risk of torsades de pointes with non-cardiac drugs. Doctors need to be aware that many drugs can cause qt prolongation.
BMJ. 2000 Apr 29;320(7243):1158-9. doi: 10.1136/bmj.320.7243.1158.
2
QTC interval prolongation and polymorphic ventricular tachycardia in association with levofloxacin.
Am J Med. 1999 Nov;107(5):528-9. doi: 10.1016/s0002-9343(99)00171-0.
3
Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance.
Drug Saf. 1998 Apr;18(4):251-72. doi: 10.2165/00002018-199818040-00002.
4
Sparfloxacin but not levofloxacin or ofloxacin prolongs cardiac repolarization in rabbit Purkinje fibers.
Fundam Clin Pharmacol. 1998;12(1):70-6. doi: 10.1111/j.1472-8206.1998.tb00926.x.
5
Hay fever drug to become prescription only.
BMJ. 1997 May 3;314(7090):1299.
6
Ethanol enhances the hemodynamic effects of felodipine.
Clin Invest Med. 1989 Dec;12(6):357-62.
Zotero 插件